Literature DB >> 22395680

Korea okays stem cell therapies despite limited peer-reviewed data.

D Yvette Wohn.   

Abstract

Mesh：

Year:  2012        PMID： 22395680     DOI： 10.1038/nm0312-329a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

Review 1.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

2.  A Road Map to Commercialization of Cartilage Therapy in the United States of America.

Authors:  BanuPriya Sridharan; Blanka Sharma; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2015-11-05       Impact factor: 6.389

Review 3.  New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation.

Authors:  Nayoun Kim; Seok-Goo Cho
Journal:  Int J Stem Cells       Date:  2015-05       Impact factor: 2.500

4.  The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine.

Authors:  Achim Rosemann; Nattaka Chaisinthop
Journal:  Soc Stud Sci       Date:  2016-02       Impact factor: 3.885

5.  Underregistration and Underreporting of Stem Cell Clinical Trials in Neurological Disorders.

Authors:  Timothy E Lee; Aryun Kim; Mihee Jang; Beomseok Jeon
Journal:  J Clin Neurol       Date:  2018-04       Impact factor: 3.077

6.  Critical attributes of human early mesenchymal stromal cell-laden microcarrier constructs for improved chondrogenic differentiation.

Authors:  Youshan Melissa Lin; Jialing Lee; Jessica Fang Yan Lim; Mahesh Choolani; Jerry Kok Yen Chan; Shaul Reuveny; Steve Kah Weng Oh
Journal:  Stem Cell Res Ther       Date:  2017-05-08       Impact factor: 6.832

7.  Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development.

Authors:  Janis Ancans
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

Review 8.  Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application.

Authors:  Mengyuan Wang; Quan Yuan; Liang Xie
Journal:  Stem Cells Int       Date:  2018-06-14       Impact factor: 5.443
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.